ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1521

Microvascular Remodeling After Autologous Stem Cell Transplant for Systemic Sclerosis

Lisa Balistreri1, Megan Sullivan1, Florentina Berianu1, Ernesto Ayala2 and Andy Abril2, 1Mayo Clinic Florida, Jacksonville, FL, 2Mayo Clinic, Jacksonville, FL

Meeting: ACR Convergence 2023

Keywords: Scleroderma, Systemic

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1513–1533) Systemic Sclerosis & Related Disorders – Clinical Poster II: Clinical Trial, Treatment & Intervention

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Autologous hematopoietic stem cell therapy (HSCT) is an effective therapy for patients with rapidly progressive systemic sclerosis (SSc) refractory to standard therapies. The disease is characterized by microvascular damage and dysfunction which can be observed using nailfold video capillaroscopy (NVC). NVC can be useful to examine the severity, activity, and stage of microvascular damage. At this time, there are few reported cases of NVC improvement after HSCT. Other therapies for SSc have not been found to provide reversal of the capillary abnormalities. Our objective was to evaluate the effect of HSCT on nailfold capillary changes in SSc.

Methods: Prospective study in patients diagnosed with SSc followed at our institution who underwent treatment with HSCT and had NVC images available pre- and post- treatment. All patients met the ACR 2013 classification criteria for SSc. Demographics, clinical features, serologies, date of diagnosis, laboratory data, last follow-up, response to treatment, NVC, and outcome were recorded. NVC was performed on all eight nailbeds using the 2nd-5th digits of both hands. Capillary morphology, density, organization, microhemorrhages, and ramifications of each nailbed were compared to determine the degree of vascular remodeling pre and post HSCT.

Results: A total of 5 patients diagnosed with SSc underwent HSCT. Mean age was 43.75 years with 4 women (80%) and 1 man (20%). Post-treatment images were collected at a median of 2 months (range 1-3 months) after HSCT. From baseline to follow-up, 80% of HSCT patients showed significant improvement in parameters including density, architecture, and microhemorrhages. The change in capillary density and disorganization to the resemblance of a normal capillary was seen in most patients. The most notable improvement was seen in one patient with scleroderma overlap syndrome with normal capillary density noted as early as one month post transplant in most of the fingers corresponding with significant clinical improvement in the modified Rodnan skin score. NVC findings showed overall positive changes with increased capillary density, reduced capillary loss, and improved capillary morphology.

Conclusion: Our findings support reversibility of the NVC changes in patients with SSc in a short time interval post HSCT. Further research is warranted to determine if microvascular improvements post HSCT contribute to the improved mortality and quality of life previously reported in the literature.

Supporting image 1

A. NVC performed prior to HSCT shows low capillary density with disorganization of the normal capillary array

B. NVC performed after HSCT shows increased capillary density to normal, hairpin-shaped capillaries, and absence of enlarged capillaries


Disclosures: L. Balistreri: None; M. Sullivan: None; F. Berianu: None; E. Ayala: None; A. Abril: None.

To cite this abstract in AMA style:

Balistreri L, Sullivan M, Berianu F, Ayala E, Abril A. Microvascular Remodeling After Autologous Stem Cell Transplant for Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/microvascular-remodeling-after-autologous-stem-cell-transplant-for-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microvascular-remodeling-after-autologous-stem-cell-transplant-for-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology